Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Japanese Journal of Clinical Oncology|August 28, 2007
Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in JapanTakayuki Yoshino, Narikazu Boku, Yusuke Onozawa, et al.
Investigational New Drugs|November 27, 2012
A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancerTakayuki Yoshino, Kentaro Yamazaki, Kensei Yamaguchi, et al.
BMC Cancer|October 28, 2022
Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancerAri Nishimura, Tomoya Yokota, Satoshi Hamauchi, et al.
Japanese Journal of Clinical Oncology|March 26, 2009
Activity of S-1 in advanced or recurrent gastric cancer patients after failure of prior chemotherapy, including irinotecan + cisplatin or fluorouracil (except S-1)Akira Ono, Narikazu Boku, Yusuke Onozawa, et al.
International Journal of Clinical Oncology|December 8, 2009
Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer: a retrospective review of 65 Japanese patientsAkihiro Tamiya, Kentaro Yamazaki, Narikazu Boku, et al.
Japanese Journal of Clinical Oncology|October 11, 2008
Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancerNozomu Machida, Takayuki Yoshino, Narikazu Boku, et al.
BMC Cancer|March 6, 2020
Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancerHiromichi Shirasu, Tomoya Yokota, Satoshi Hamauchi, et al.
International Journal of Clinical Oncology|October 25, 2011
Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancerTakahiro Tsushima, Shuichi Hironaka, Narikazu Boku, et al.
International Journal of Clinical Oncology|June 21, 2021
Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neckAri Nishimura, Tomoya Yokota, Satoshi Hamauchi, et al.
Japanese Journal of Clinical Oncology|October 8, 2011
S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapyTomoya Yokota, Yusuke Onozawa, Narikazu Boku, et al.
Pageof 11